Table 4.

Antibiotic resistance pattern based on sample type

Year	Antibiotic resistance
2013	The blood sample was associated with antibiotic resistance to vancomycin (p = 0.001), oxacillin (p = 0.021), ceftriaxone (p = 0.002), cefipime (p = 0.013), linzolide (p = 0.003) and clindamycin (p = 0.015). A sample of phlegm was associated with antibiotic resistance to piperacillin / tazobactam (p = 0.001), meropenem (p = 0.001), amikacin (p = 0.001) while the urine sample was related to antibiotic resistance to nalidixic acid (p = 0.001).
2014	Blood samples were correlated with antibiotic resistance to ceftriaxone (p = 0.001), Cefepime (p = 0.001), meropenem (p = 0.001), amikacin (p = 0.001), and colistin (p = 0.040). The association of sputum samples with antibiotic resistance was detected in a number of bacteria including piperacillin / tazobactam (p = 0.001), ceftazidime (p = 0.043), imipenem (p = 0.001), gentamicin (p = 0.001), and ciprofloxacin (p = 0.001).
2015	The association of blood samples with antibiotic resistance was observed only in ceftriaxone (p = 0.001) and cefepime (p = 0.001). Furthermore, the sputum samples had a significant relationship with antibiotics in terms of drug resistance including piperacillin / tazobactam (p = 0.001), imipenem (p = 0.001), moropenem (p = 0.001) and amikacin (p = 0.001) ciprofloxacin (pp = 0.027) and levofloxacin (p = 0.016). While urine specimens were associated with antibiotic resistance to co-trimoxazole (p = 0.005)